Concepedia

M. Ingham

MI

Statistics

Publications

2

Citations

289

H-Index

2

Active since

2018

Affiliations

Columbia University Irving Medical Center(Current)

Institute of Cancer Research

M. Ingham is an author at Columbia University Irving Medical Center specializing in immunology, type i interferon pathways, and cancer immunotherapy.

Publications per year

2018–2021

2

Publications

2

Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas

Kevin J. Harrington, Joshua Brody, M. Ingham et al. · Annals of Oncology · 2018 · 276 citations · Full text

, , +15

Abstract CT217: Phase I, first-in-human trial evaluating BI 1387446 (STING agonist) alone and in combination with ezabenlimab (BI 754091; anti-PD-1) in solid tumors

Kevin J. Harrington, Eileen E. Parkes, Jared Weiss et al. · Cancer Research · 2021 · 13 citations

, , +17

1–2 of 2